Ekkio Capital annonce l’acquisition de FX Solutions,

acteur de référence de l’arthroplastie de l’épaule

LOGO FX

Ekkio Capital, spécialiste de l’investissement dans la santé et les PME de croissance, annonce l’acquisition de la majorité du capital de FX Solutions, numéro deux français de l’arthroplastie de l’épaule. La famille du fondateur (Jean-Jacques Martin) reste actionnaire, aux côtés du management. A cette occasion, le nouveau Président, Bruno Thevenet, entre également au capital et KREAXI, ESFIN PARTICIPATIONS et Rhône Dauphiné Développement signent leur sortie.

Après avoir fondé Fixano en 1987, fabricant des implants pour les chirurgies osseuses et articulaires, finalement vendu à l’américain Viscogliosi Brothers en 2005, Jean-Jacques Martin a créé la société FX Solutions en 2011, spécialisée dans la conception et la commercialisation d’implants et d’instruments chirurgicaux exclusivement dédiés à l’arthroplastie de l’épaule.

Deuxième acteur du marché français avec plus de 3 000 prothèses vendues en 2017, FX Solutions a développé une offre unique et innovante de prothèses d’épaules. Homologuée aux Etats-Unis (FDA), sa large gamme de produits répond à l’ensemble des besoins (omarthrose / traumatologie).

Positionné sur le marché des extrémités, un des segments les plus dynamiques des implants orthopédiques (10% de croissance par an), FX Solutions a généré une croissance annuelle moyenne de son chiffre d’affaires de plus de 60% depuis sa création et prévoit de garder le même rythme en 2018. Avec une approche très technique et orientée service client, la commercialisation est réalisée en direct en France (58% du CA) par une équipe dédiée.

La société réalise aujourd’hui près de la moitié de son activité à l’international, dans 45 pays, et dispose d’un potentiel de croissance très important, notamment aux États-Unis, 1er marché mondial.

Jean-Jacques Martin, chef d’entreprise visionnaire, a souhaité adosser FX Solutions à un investisseur français, garant de la continuité du projet d’entreprise, avec des moyens renforcés, en vue d’accélérer son développement.

« Cette opération s’inscrit dans le cadre d’une démarche sectorielle approfondie dans l’orthopédie, que nous conduisons avec Bruno Thevenet depuis plus d’un an. Nous avons été séduits par les fondamentaux solides de FX Solutions : une gamme de produits large et reconnue par les chirurgiens, une excellente équipe de management, une force commerciale technique et spécialisée, et enfin un fort potentiel de développement aux Etats-Unis. » déclare Jean-Marc Sceo, Président d’Ekkio Capital.

Intervenants sur l’opération :

Acquéreurs :

Ekkio Capital (Jean-Marc Sceo, Alexandre Colcombet) ; Bruno Thevenet

Conseils acquéreur :

Conseil M&A acheteur : Potomac (Sébastien Drouot, Ahmed Soibah-Eddine)

Juridique : Dechert (Pierre-Henri Brieau, Alexia Delahousse, Anne-Charlotte Rivière, Sophie Pelé, Jessica Garestier, Antoine Le Touzé)

Avocats financeur : Herbert Smith Freehills (Laure Bonin, Noémie Laurin, Emmanuel Le Galloc’h)

Audit Financier : Deloitte (Thomas Fischer, Steven Bérard, Benjamin Deloffre)

Audit Stratégique : LEK (Arnaud Sergent, André Isak, Jean-Guillaume Bayada, Maxime Julian)

Financeur : CIC Private Debt (Francois Petit, Gaspard de Longeaux, Adrien Normand)

Cédants :

Famille Martin ; Management ; ESFIN Participations (Philippe Céas) ; KREAXI (Isabelle BOU ANTOUN); Rhône Dauphiné Développement (Pierre Jourdain)

Conseils cédants :

Financier : UBS M&A Mid-Cap (Jérôme Breuneval, Julien Lafarge, Maxime Moreira)

Juridique : Lexcase (Guillaume Pierson, Pénélope Bouchard, Simon Wesley)

A propos d’Ekkio Capital

Ekkio Capital est une société de capital-investissement indépendante agréée par l’Autorité des Marchés Financiers (AMF), qui investit depuis plus de 15 ans dans la croissance et la transformation de PME françaises et européennes. Ses secteurs d’expertise sont la Santé, le Tourisme et Loisirs ainsi que le Contrôle Réglementé (TIC).

www.ekkio.fr

 

Contact médias

Citigate Dewe Rogerson

Daiana Hirte Boccaccio

01 53 32 78 90 / 07 60 90 89 12

daiana.hirteboccaccio@citigatedewerogerson.com

BUILD UPSterience

Sterience pickaxe at German Vanguard for his first  add-on

By WS ¦ 28/09/2017 ¦ 10:38

A little more than two years after having “spinned-off” Sterience of the perimeter of Dalkia, Ekkio Capital accompanies this leader of outsourced sterilization of medical equipment in his first one build-up. The acquisition concerns an expert of the complex medical devices, Vanguard Medical Services France, the subsidiary of the german Vanguard. He appears …

read the full article on capitalfinance.lesechos.fr (french version only)

 

Ekkio Capital has signed an exclusive agreement with Eurofins for the sale of Amatsigroup

Paris, July 10th, 2017 – Ekkio Capital, a sector-based investor dedicated to high-potential European SMEs, announces that it has signed an exclusive agreement with Eurofins (EUFI.PA), a global leader in bio-pharmaceutical products testing, and one of the world leaders in genomic services, for the sale of Amatsigroup. The company is a leading international contract development and manufacturing organization (CDMO) providing preclinical and clinical services for the development of human and veterinary drugs.

Founded in 2010 by Ekkio Capital, Amatsigroup was formed through the merger of four companies (Avogadro, Amatsi, DBI and Avepharm) and has grown though several strategic acquisitions: SEPS Pharma (Belgium), Amatsigroup Inc. (USA) in 2014, Pierre Fabre’s pharmaceutical analysis laboratory in 2015, QBiologicals (Belgium) in 2016, Disposable Lab early 2017 and more recently two sites of Bertin Pharma.

Over the past 6 years, Amatsigroup became one of the largest independent multispecialist platform in Europe with a unique proposal for specialty and biopharma clients, including pharmaceutical analysis, formulation development and manufacturing, biological research & development, among other services. The company has about 450 employees over 8 sites in France, 2 sites in Belgium and 1 site in the USA.

Given its unique positioning as a high value added multi-specialist drug development services provider, the company is well-positioned to leverage and strengthen its footprint in the CDMO industry.

The contemplated transaction is expected to be completed over the next few months, subject to customary closing conditions including employees’ representatives’ information and consultation.

Councels of the operation :

  • Operation : Rothschild – F. de BRETEUIL / R. ROZEMULDER / E. GIORNI
  • Legal : Willkie Farr Gallagher – C. GARAUD / V. SAYAG
  • Finance : Deloitte – T. FISCHER
  • Tax and Social : Bureau Francis Lefebvre – P. GOSSET / V. DELAGE

About Ekkio Capital

Ekkio Capital is an independent private equity firm funded by institutional investors, regulated by the French AMF (Autorité des marchés financiers) and investing for more than 15 years in high potential growth French and European SMEs. Specialising in Tourism & Leisure, Health care and TIC (Testing, Inspection & Certification), Ekkio Capital has today more than €230m under management and has successfully achieved 30 buy-out and development transactions.

www.ekkio.fr

Medias contact

Citigate Dewe Rogerson

Daiana Hirte

01 53 32 78 92 / 07 60 90 89 12

daiana.hirte@citigate.fr

And one, and two, and three lion cubs at the Safari Zoo Domaine de Thoiry !

20170609_Thoiry_Lionceaux

It was on March 24th of this year they :  three adorable baby lions  of Africa were born in the Safari Zoo Domain of Thoiry and have just just made their first exit!

First steps

Sheltered in an special room with their mother until  June 9th, three small “big cats” grew up serenely and are now  old enough to discover the outside world! Both females and their brother are the descendants of Akele, 5,5-year-old male, and of Nyassa, 3 years old. Although it is its first litter, Nyassa takes care of it perfectly well

petit lion

At the age of one and a half month, while lion cubs began to be less dependent on their mother and before they do not become too powerful, the team of the park was able to proceed to their sexing and to their puçage. This last manipulation consists in inserting under the skin a chip containing all the medical and genetic information of each of them. It is an important stage because, unless a health problem, it is the unique moment when they will have been in direct contact with the Man.

In their natural environment, the lions of Africa undergo more and more the anthropological pressure.

This weekend, the three scions of Nyassa made their first exit in front of the visitors. They took up a new space, where they can be from now on observed throughout the season. From now on, two groups of lions can be observed by the public.

Give your vote!

From this week, the team makes an appointment with the Internet users on the Facebook of the park (@zoothoiry) to choose the first names of youngs!

A new date in a few weeks, the lions of the Safari Zoo Domain of Thoiry will not stop surprising you … And one, and two, and three lion cubs at the Safari Zoo Domain of Thoiry!

Paris, le 23 février 2017 –Sterience, the French leader in sterilization (in-situ and ex-situ) of medical devices for the surgical environment, announces the arrival of Pierre Forest as President.

Recognized professional in health care, Pierre Forest will replace Jacques Penicaud, who has been the head of the group since its acquisition by Ekkio Capital in 2015. After a first phase of restructuring, the company now focuses its strategy on commercial development and geographical expansion.

Photo Pierre Forest

A graduate of an HEC MBA and the French Institute of Business and Management, Pierre Forest has more than 30 years experience in sales, marketing and general management of industrial and technological companies in the health sector. He began his career in medical imaging groups before taking up the position of Chief Executive Officer of the Acuson Corporation between 1994 and 2001. He then joined Siemens Medical as Head of the Ultrasound Division for Western Europe.

At the beginning of 2005 his career was in life sciences and in vitro diagnostics. He was appointed Managing Director of Applera France SA and then Abbott France Diagnostics in 2007. These various positions enabled him to acquire a wealth of experience in the direct environment of the care path in medical biology and in the management of teams with diversified profiles. Between 2011 and 2015, Pierre Forest was President of Novescia SAS, France’s leading medical biology network combining clinical and routine. Pierre and his teams successfully completed one of the first consolidations of liberal biology activities in a structured healthcare company. This project was completed by a sale to the Cerba Health Care Group (PAI Partners).

About Sterience: Created in 2001, Sterience is the French leader in sterilization (in-situ and ex-situ) of surgical instruments that can be reused in operating theaters. Thanks to its 260 employees, the group processes more than 700,000 medical devices per year in its 8 sterilization centers in France. Sterience has recently initiated the construction of a new central sterilization site in Reims in partnership with the Courlancy Santé group, an emblematic project of the group’s ability to manage the management of complex and large projects. Ekkio Capital acquired the entire capital in January 2015.

Http://www.sterience.fr/

 

Contact médias : Citigate Dewe Rogerson
Daiana HIRTE 01 53 32 78 90 / 07 60 90 89 12 daiana.hirte@citigate.fr

CGH introduces “Chalets de Cœur”

Chalets de Cœur (CGH Group) is specialized in sales of stays in selected mountain chalets  including hotel services, and offers a rental management service to private owners.

chalet4

 

discover the website

Un nouveau directeur général à la tête du Groupe Thoiry

Thierry Duguet, 55 ans, est nommé directeur général du Groupe Thoiry et des quatre parcs zoologiques
qui le composent.

Spécialiste du marketing et de l’événementiel, ancien élève de Sciences Po Paris, il a notamment occupé des postes de Direction Marketing au sein de grandes entreprises hightech comme Atari (1988-1990), Compaq-HP (1990-2001) ou encore Bouygues Telecom (2005-2010). Directeur Associé de l’agence d’évènements Connect Factory entre 2001 et 2005, il était, depuis 2010, vice-président Europe de la filiale «CWT Meetings & Events» de Carlson Wagonlit Travel.

Thierry Duguet assurera une période de transition à la tête du groupe conjointement avec l’actuel dirigeant, Olivier Méliz, et le remplacera définitivement lors du départ de ce dernier, fin 2017.

Cette nomination va de pair avec la volonté affichée du Groupe Thoiry d’entamer un cycle ambitieux de développement depuis la prise de participation majoritaire par Ekkio Capital, en septembre 2015. Des investissements importants et la création d’innovations, dans le but de renouveler l’offre, seront les moteurs de cette croissance qui s’inscrira dans l’esprit des origines du Parc et Château de Thoiry fondé par Paul de La Panouse.